PEB - Pacific Edge Ltd

[hilskin]

https://www.nzx.com/companies/PEB/announcements/261058

[Carpenterjoe]

classic PEB.......... company has gone out of their way,several times, to say they will not be forecasting sales due to so many unknowns
yet today they say sales are tracking expectations......... and who's expectation will those be.... the cleaning ladies or insto's or maybe the taxi drivers.
Total rhetoric

hmmmmm. I thought lack of sales information was to help maintain competitive advantage? (Complete opposite to Xero, I know which strategy I prefer).
I suppose it really comes down to shareholder trust, I have a lot more trust in Darling than Key.

[hilskin]

Hi Penn, two announcements today :-)

Title	Date	Type
Pacific Edge issued patent in Europe for gastri...	24 Feb 2015, 3:43pm	GENERAL
European Patent Office grants PE patent for Cxb...	24 Feb 2015, 12:56pm	GENERAL

[penn]

Ah thanks I could not see the 12.56 one on the NZX!
But if the Gastric news is price sensitive, why release it at 3:43pm
surely the European patent office don't send out e-mails at 1:00am.

[klid]

Ah thanks I could not see the 12.56 one on the NZX!
But if the Gastric news is price sensitive, why release it at 3:43pm
surely the European patent office don't send out e-mails at 1:00am.

Curious. They mustn't have known at the time of the first announcement.

The first announcement only has this is mention to gastric cancer:

NZX Announcement ID 261056
Meanwhile Pacific Edge has been rapidly extending its portfolio of intellectual property based on its molecular diagnostic technology with the recent grant of patents in the US for the prognosis of melanoma, in Japan for the prognosis of colorectal cancer and in China for the detection of gastric cancer.

And interestingly there was a buy on the first announcement but not the second.

[skid]

They may have been trying to get more bang for their buck....There was a small flurry..but things soon settled a tad higher than start--1c in the end----i think that sort of thing needs to be backed by hard sales at this point...some indication that things are in fact going forward at an acceptable rate.

[pierre]

I haven't had a direct reply to my request - they must have been too busy preparing today's announcement. That will do in the meantime.

The FY15 financials will be revealed late May so patience required for the next few months while they count the money that appears to be starting to come in from the US market.

Maybe the product line up is Ok and the (former) doom & gloom merchants on PEB might be proved wrong.

I received the following response from the Commercial Director of PEB late this afternoon:

"Thank you for your email. There won’t be any interim updates provided outside of the the formal announcements provided by the company at the key specified times of year i.e. year end and half year announcement dates. Outside of this we continue to announce to the market any additional material events as required by continuous disclosure rules of the FMA.

In that regard we did make two announcements today relating to the recent issue of additional patents in Europe for our Cxbladder, and Melanoma technology (see below), with some reference to our current progress in the US with Cxbladder.

http://www.pacificedgedx.com/news-an...-for-cxbladder
http://www.pacificedgedx.com/news-an...gastric-cancer

Thank you for your continued support, patience and interest in Pacific Edge."

[Minerbarejet]

I received the following response from the Commercial Director of PEB late this afternoon:

"Thank you for your email. There won’t be any interim updates provided outside of the the formal announcements provided by the company at the key specified times of year i.e. year end and half year announcement dates. Outside of this we continue to announce to the market any additional material events as required by continuous disclosure rules of the FMA.

In that regard we did make two announcements today relating to the recent issue of additional patents in Europe for our Cxbladder, and Melanoma technology (see below), with some reference to our current progress in the US with Cxbladder.

http://www.pacificedgedx.com/news-an...-for-cxbladder
http://www.pacificedgedx.com/news-an...gastric-cancer

Thank you for your continued support, patience and interest in Pacific Edge."

All very well and good but where is the reference to Melanoma in Europe in the announcements- maybe thats coming tomorrow.

[pierre]

All very well and good but where is the reference to Melanoma in Europe in the announcements- maybe thats coming tomorrow.

He didn't mention Melanoma in Europe - you must have missed the comma after Cxbladder in the second paragraph of the response.
Cheers
Pierre

[Balance]

I’m sorry to have to say that you may well be disappointed in your analysis Whipmoney, PEB told us at the time of the AGM that they could break even this financial year [1]. IMHO it’s more likely to be HY15 (November 2014).

My estimate is that this would require circa 21,000 US tests to cover costs and to turn a profit, but then as we know, PEB have already also told us that they expect to be “processing several tens of thousands of tests” within 2014 [2].

And well yes, most informed shareholders would actually see R&D as a positive within a company like PEB full of extraordinary research people and with a history of performing such R&D at one tenth the cost of what it may otherwise cost abroad [3].

The more well managed R&D, the more products entering the commercialisation pipeline, the more long term cashflows generated, fantastic.

References:

1. http://www.odt.co.nz/news/business/2...-100m-forecast
2. http://www.odt.co.nz/news/business/2...-edge-business
3. http://www.nzherald.co.nz/business/n...ectid=11178639

The post above is an indication of closely posters and investors follow comments and expectations of PEB's management.

I guess it means PEB is currently running at least a year behind schedule, maybe 2 years.